ASSIST: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1868, Poster Board= SUN-051

Irene Noronha Poster Presenter